Estrogen–progestin replacement therapy and breast cancer risk: the Women's Health Study (United States)

By Porch J.V.  

Cancer Causes and Control, Vol. 13, Iss. 9, 2002-11 ,pp. : 847-854

Springer Publishing Company

Access to resources Recommend Favorite

The Effect of Estrogen Plus Progestin Hormone Therapy on Breast Cancer Mortality: Still Unresolved

By Schairer Catherine   Brinton Louise A.  

Journal of the National Cancer Institute, Vol. 105, Iss. 8, 2013-04 ,pp. : 513-514

Oxford University Press

Access to resources Recommend Favorite

Multivitamin and mineral use and breast cancer mortality in older women with invasive breast cancer in the women’s health initiative

By Wassertheil-Smoller S.   McGinn A.   Budrys N.   Chlebowski R.   Ho G.   Johnson K.   Lane D.   Li W.   Neuhouser M.   Saquib J.   Shikany J.   Song Y.   Thomson C.  

Breast Cancer Research and Treatment, Vol. 141, Iss. 3, 2013-10 ,pp. : 495-505

Springer Publishing Company

Access to resources Recommend Favorite

Discovery and preliminary confirmation of novel early detection biomarkers for triple-negative breast cancer using preclinical plasma samples from the Women's Health Initiative observational study

By Li Christopher  

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 611-618

Springer Publishing Company

Access to resources Recommend Favorite

Estrogen and estrogen–progestin replacement therapy and risk of postmenopausal breast cancer in Canada

By Kirsh V.  

Cancer Causes and Control, Vol. 13, Iss. 6, 2002-08 ,pp. : 583-590

Springer Publishing Company

Access to resources Recommend Favorite